Suspension of marketing authorization for ingenol mebutate.
Saved in:
| Title: | Suspension of marketing authorization for ingenol mebutate. |
|---|---|
| Authors: | Mohd Mustapa MF; British Association of Dermatologists, Clinical Standards Unit, London, UK., de Berker D; Department of Dermatology, Bristol Royal Infirmary, Bristol, UK., McGregor JM; Department of Dermatology, Barts Health NHS Trust, London, UK., Exton LS; British Association of Dermatologists, Clinical Standards Unit, London, UK., Hughes BR; Portsmouth Dermatology Centre, Portsmouth Hospitals NHS Trust, Portsmouth, UK., Levell NJ; Norfolk and Norwich University Hospital, Norwich, UK. |
| Source: | The British journal of dermatology [Br J Dermatol] 2020 Oct; Vol. 183 (4), pp. 792. Date of Electronic Publication: 2020 Jul 27. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1365-2133 |
|---|---|
| DOI: | 10.1111/bjd.19330 |
